MEI Pharma Inc. (MEIP)
NASDAQ: MEIP
· Real-Time Price · USD
4.67
-0.21 (-4.30%)
At close: Aug 19, 2025, 3:59 PM
MEI Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 20.47M | 23.74M | 6.95M | 3.71M | 2.37M | 5.17M | 3.37M | 16.91M | 8.81M | 10.92M | 14.65M | 15.74M | 11.11M | 12.55M | 15.62M | 8.54M | 9.74M | 9.88M | 10.96M |
Short-Term Investments | n/a | n/a | 19.95M | 34.64M | 54.18M | 54.31M | 78.83M | 83.79M | 103.22M | 113.26M | 123.71M | 137.51M | 157.93M | 173.2M | 129.88M | 144.88M | 154.88M | 170.27M | 165.18M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.92M | n/a | n/a | 11.11M | 12.55M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.28M | -13.7M | -10.92M | n/a | -10.71M | -11.11M | -12.55M | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 85K | 4.58M | 5.7M | 7.76M | 10.04M | 8.45M | 10.15M | 18.12M | 7.58M | n/a | n/a | 25.92M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.45M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 74K | 71K | 840K | 1.37M | 2.81M | 6.69M | 6.22M | 6.75M | 3.87M | 3.57M | 2.78M | 3.83M | n/a | n/a | n/a | n/a | 11.94M | 13.89M | 20.42M |
Total Current Assets | 20.78M | 24.39M | 27.75M | 40.77M | 59.37M | 66.17M | 88.42M | 107.53M | 120.48M | 133.44M | 148.91M | 167.13M | 183.47M | 200.72M | 167.36M | 164.82M | 176.56M | 194.03M | 203.93M |
Property-Plant & Equipment | n/a | n/a | 5K | 606K | 11.89M | 12.37M | 12.83M | 13.28M | 13.7M | 14.15M | 14.68M | 10.71M | 10.96M | 8.74M | 8.99M | 9.28M | 9.56M | 9.85M | 10.08M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | 5K | 606K | 11.89M | 12.37M | 12.83M | 13.28M | 13.7M | 14.15M | 14.68M | 10.71M | 10.96M | 8.74M | 8.99M | 9.28M | 9.56M | 9.85M | 10.08M |
Total Assets | 20.78M | 24.39M | 27.75M | 41.38M | 71.26M | 78.54M | 101.25M | 120.81M | 134.19M | 147.6M | 163.58M | 177.84M | 194.43M | 209.46M | 176.35M | 174.1M | 186.12M | 203.88M | 214.01M |
Account Payables | 177K | 596K | 976K | 3.17M | 3.18M | 1.38M | 3.22M | 6.13M | 4.39M | 4.07M | 8.42M | 7.92M | 8.26M | 6.26M | 8.47M | 6.36M | 5.57M | 5.55M | 6.38M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 317K | 1.58M | 2.9M | 4.5M | 4.83M | 4.79M | 13.52M | 14.84M | 14.61M | 19.14M | 19.48M | 18.97M |
Short-Term Debt | n/a | n/a | n/a | n/a | 1.05M | n/a | 1.05M | 1.43M | 1.39M | 1.34M | 1.3M | 871K | 828K | 987K | 957K | 928K | 900K | 873K | 602K |
Other Current Liabilities | 752K | 1.48M | 503K | 2.82M | 1.7M | 2.24M | 460K | 5.76M | -1.39M | -1.34M | -1.3M | 5.6M | -828K | -987K | -957K | 3.96M | -1.8M | -873K | -602K |
Total Current Liabilities | 1.24M | 2.29M | 2.87M | 8.36M | 9.62M | 8.04M | 8.56M | 20.34M | 23.62M | 22.65M | 23.43M | 24.44M | 23.96M | 30.52M | 30.36M | 30.29M | 33.38M | 37.01M | 31.49M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 486K | 1.6M | 1.54M | 14.31M | 19.77M | 22.36M | 29.44M | 20.18M | 27.26M |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | 10.62M | 11.01M | 11.33M | 75.84M | 76.21M | 76.57M | 102.84M | 100.98M | 102.67M | 101.69M | 114.16M | 102.44M | 107.78M | 93.37M | 100.19M |
Total Liabilities | 1.24M | 2.29M | 2.87M | 8.36M | 20.23M | 19.05M | 19.89M | 96.19M | 99.83M | 99.22M | 126.28M | 125.43M | 126.62M | 132.21M | 144.52M | 132.74M | 141.16M | 130.38M | 131.68M |
Total Debt | n/a | n/a | n/a | n/a | 11.67M | 12.03M | 12.38M | 12.73M | 13.05M | 13.37M | 13.68M | 9.64M | 2.36M | 7.84M | 8.07M | 8.3M | 8.51M | 8.71M | 8.67M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -401.48M | -398.9M | -396.23M | -388.22M | -369.81M | -360.69M | -349.62M | -406M | -395.97M | -380.53M | -390.78M | -374.16M | -358.1M | -345.45M | -339.69M | -327.81M | -322.09M | -290.78M | -279.33M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 19.54M | 22.1M | 24.88M | 33.02M | 51.03M | 59.49M | 81.36M | 24.62M | 34.35M | 48.37M | 37.31M | 52.41M | 67.81M | 77.25M | 31.83M | 41.36M | 44.96M | 73.5M | 82.33M |
Total Investments | n/a | n/a | 19.95M | 34.64M | 54.18M | 54.31M | 78.83M | 83.79M | 103.22M | 124.17M | 123.71M | 137.51M | 169.04M | 185.75M | 129.88M | 144.88M | 154.88M | 170.27M | 165.18M |